Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients

Anterior gradient protein (AGR) 3 is a highly related homologue of pro-oncogenic AGR2 and belongs to the family of protein disulfide isomerases. Although AGR3 was found in breast, ovary, prostate, and liver cancer, it remains of yet poorly defined function in tumorigenesis. This study aimed to determine AGR3 expression in a cohort of 129 primary breast carcinomas and evaluate the clinical and prognostic significance of AGR3 in these tumors. The immunohistochemical analysis revealed the presence of AGR3 staining to varying degrees in 80% of analyzed specimens. The percentage of AGR3-positive cells significantly correlated with estrogen receptor, progesterone receptor (both P<0.0001) as well as low histological grade (P=0.003), and inversely correlated with the level of Ki-67 expression (P<0.0001). In the whole cohort, AGR3 expression was associated with longer progression-free survival (PFS), whereas AGR3-positive subgroup of low-histological grade tumors showed both significantly longer PFS and overall survival. In conclusion, AGR3 is associated with the level of differentiation, slowly proliferating tumors, and more favorable prognosis of breast cancer patients.

[1]  Peter Widmayer,et al.  Genevestigator V3: A Reference Expression Database for the Meta-Analysis of Transcriptomes , 2008, Adv. Bioinformatics.

[2]  Pierre Legrain,et al.  Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer* 210 , 2003, The Journal of Biological Chemistry.

[3]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[4]  M. Hermanová,et al.  Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. , 2014, Experimental and molecular pathology.

[5]  E. Chevet,et al.  Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development , 2013, Oncogene.

[6]  G. Kristiansen,et al.  Prognostic Relevance of AGR2 Expression in Breast Cancer , 2006, Clinical Cancer Research.

[7]  B. Vojtesek,et al.  The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers , 2010, Oncogene.

[8]  W. Weichert,et al.  Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma , 2012, Virchows Archiv.

[9]  H. Weintraub,et al.  Progressive determination during formation of the anteroposterior axis in Xenopus laevis , 1989, Cell.

[10]  Hong Wang,et al.  The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development. , 2012, Developmental biology.

[11]  S. Hudak,et al.  Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin , 2010, Breast Cancer Research.

[12]  H. Klocker,et al.  Anterior gradient 2 and 3 – two prototype androgen‐responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells , 2013, The FEBS journal.

[13]  Michael J. Birrer,et al.  The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated With Differentiation and Survival in Ovarian Cancer , 2011, The American journal of surgical pathology.

[14]  B. Vojtesek,et al.  Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2. , 2013, Cancer letters.

[15]  Feras Hatahet,et al.  Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. , 2009, Antioxidants & redox signaling.

[16]  M. Schenker,et al.  hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan , 2003, British Journal of Cancer.

[17]  H. Stunnenberg,et al.  ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands , 2009, The EMBO journal.

[18]  S. Pastoreková,et al.  The role of AGR2 and AGR3 in cancer: similar but not identical. , 2015, European journal of cell biology.

[19]  P. Rudland,et al.  Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients , 2006, British Journal of Cancer.

[20]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[21]  P. Hirvikoski,et al.  Identification of androgen-regulated genes in human prostate , 2012, Molecular medicine reports.

[22]  Henry Z. Montes,et al.  TNM Classification of Malignant Tumors, 7th edition , 2010 .

[23]  J. Winstanley,et al.  The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. , 2009, The American journal of pathology.

[24]  Dong Liu,et al.  Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. , 2005, Cancer research.

[25]  Kyusam Choi,et al.  AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration , 2011, Experimental & Molecular Medicine.

[26]  K. Pienta,et al.  Global gene expression profiling of circulating tumor cells. , 2005, Cancer research.

[27]  E. Liu,et al.  An Oestrogen Receptor α-bound Human Chromatin Interactome , 2009, Nature.

[28]  B. Vojtesek,et al.  Anterior gradient 2: a novel player in tumor cell biology. , 2011, Cancer letters.

[29]  Fang Zhao,et al.  The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker , 2013, Breast Cancer Research.

[30]  T. Hupp,et al.  Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. , 2012, Journal of immunological methods.

[31]  M. Korc,et al.  AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia , 2012, Oncogene.

[32]  C. Windpassinger,et al.  Localization1 of the human anterior gradient-2 gene (AGR2) to chromosome band 7p21.3 by radiation hybrid mapping and fluorescencein situ hybridisation , 2000, Cytogenetic and Genome Research.

[33]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[34]  D. Maeda,et al.  Agr2 mediates paracrine effects on stromal fibroblasts that promote invasion by gastric signet-ring carcinoma cells. , 2015, Cancer research.

[35]  G. Ermakova,et al.  Agr genes, missing in amniotes, are involved in the body appendages regeneration in frog tadpoles , 2013, Scientific Reports.

[36]  A Howell,et al.  Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. , 2006, Endocrine-related cancer.

[37]  B. Vojtesek,et al.  AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients , 2013, Disease markers.

[38]  Huamin Wang,et al.  New Blocking Antibodies against Novel AGR2–C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice , 2015, Molecular Cancer Therapeutics.

[39]  R. Weigel,et al.  hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. , 1998, Biochemical and biophysical research communications.